| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9338 |
| Human Intestinal Absorption | HIA+ | 0.9760 |
| Caco-2 Permeability | Caco2+ | 0.7171 |
| P-glycoprotein Substrate | Non-substrate | 0.6187 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7581 |
| Non-inhibitor | 0.9383 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8689 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9086 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8514 |
| CYP450 2D6 Substrate | Non-substrate | 0.8853 |
| CYP450 3A4 Substrate | Non-substrate | 0.6257 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6006 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6511 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8898 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5322 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9319 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6528 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9301 |
| Non-inhibitor | 0.9304 |
| AMES Toxicity | Non AMES toxic | 0.9472 |
| Carcinogens | Non-carcinogens | 0.7081 |
| Fish Toxicity | High FHMT | 0.9199 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9977 |
| Honey Bee Toxicity | High HBT | 0.5515 |
| Biodegradation | Ready biodegradable | 0.8886 |
| Acute Oral Toxicity | IV | 0.5493 |
| Carcinogenicity (Three-class) | Warning | 0.5214 |